325 related articles for article (PubMed ID: 11423566)
1. Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis.
Lema GP; Maier H; Nieto E; Vielhauer V; Luckow B; Mampaso F; Schlöndorff D
J Am Soc Nephrol; 2001 Jul; 12(7):1369-1382. PubMed ID: 11423566
[TBL] [Abstract][Full Text] [Related]
2. Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice.
Anders HJ; Belemezova E; Eis V; Segerer S; Vielhauer V; Perez de Lema G; Kretzler M; Cohen CD; Frink M; Horuk R; Hudkins KL; Alpers CE; Mampaso F; Schlöndorff D
J Am Soc Nephrol; 2004 Jun; 15(6):1504-13. PubMed ID: 15153561
[TBL] [Abstract][Full Text] [Related]
3. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
[TBL] [Abstract][Full Text] [Related]
4. Enhanced osteopontin expression and macrophage infiltration in MRL-Fas(lpr) mice with lupus nephritis.
Wüthrich RP; Fan X; Ritthaler T; Sibalic V; Yu DJ; Loffing J; Kaissling B
Autoimmunity; 1998; 28(3):139-50. PubMed ID: 9867126
[TBL] [Abstract][Full Text] [Related]
5. Chemokine and chemokine receptor expression during initiation and resolution of immune complex glomerulonephritis.
Anders HJ; Vielhauer V; Kretzler M; Cohen CD; Segerer S; Luckow B; Weller L; Gröne HJ; Schlöndorff D
J Am Soc Nephrol; 2001 May; 12(5):919-931. PubMed ID: 11316850
[TBL] [Abstract][Full Text] [Related]
6. Transcription factor Fli-1 impacts the expression of CXCL13 and regulates immune cell infiltration into the kidney in MRL/lpr mouse.
Sato S; Zhang XK; Matsuoka N; Sumichika Y; Saito K; Yoshida S; Matsumoto H; Temmoku J; Fujita Y; Asano T; Migita K
Lupus Sci Med; 2023 Apr; 10(1):. PubMed ID: 37094946
[TBL] [Abstract][Full Text] [Related]
7. Protective role for CCR5 in murine lupus nephritis.
Turner JE; Paust HJ; Bennstein SB; Bramke P; Krebs C; Steinmetz OM; Velden J; Haag F; Stahl RA; Panzer U
Am J Physiol Renal Physiol; 2012 Jun; 302(11):F1503-15. PubMed ID: 22442210
[TBL] [Abstract][Full Text] [Related]
8. The Friend leukaemia virus integration 1 (Fli-1) transcription factor affects lupus nephritis development by regulating inflammatory cell infiltration into the kidney.
Sato S; Zhang XK
Clin Exp Immunol; 2014 Jul; 177(1):102-9. PubMed ID: 24580413
[TBL] [Abstract][Full Text] [Related]
9. (5R)-5-hydroxytriptolide ameliorates lupus nephritis in MRL/
Zhang LY; Li H; Wu YW; Cheng L; Yan YX; Yang XQ; Zhu FH; He SJ; Tang W; Zuo JP
Am J Physiol Renal Physiol; 2017 Apr; 312(4):F769-F777. PubMed ID: 28100505
[TBL] [Abstract][Full Text] [Related]
10. Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice.
Hasegawa H; Kohno M; Sasaki M; Inoue A; Ito MR; Terada M; Hieshima K; Maruyama H; Miyazaki J; Yoshie O; Nose M; Fujita S
Arthritis Rheum; 2003 Sep; 48(9):2555-66. PubMed ID: 13130475
[TBL] [Abstract][Full Text] [Related]
11. Involvement of infiltrating macrophage-derived activin A in the progression of renal damage in MRL-lpr mice.
Kadiombo AT; Maeshima A; Kayakabe K; Ikeuchi H; Sakairi T; Kaneko Y; Hiromura K; Nojima Y
Am J Physiol Renal Physiol; 2017 Feb; 312(2):F297-F304. PubMed ID: 27881396
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid treatment protects MRL/lpr lupus mice from the development of glomerular disease.
Pérez de Lema G; Lucio-Cazaña FJ; Molina A; Luckow B; Schmid H; de Wit C; Moreno-Manzano V; Banas B; Mampaso F; Schlöndorff D
Kidney Int; 2004 Sep; 66(3):1018-28. PubMed ID: 15327395
[TBL] [Abstract][Full Text] [Related]
13. The fungal lactone oxacyclododecindione is a potential new therapeutic substance in the treatment of lupus-associated kidney disease.
Henke J; Erkel G; Brochhausen C; Kleinert H; Schwarting A; Menke J; Pautz A
Kidney Int; 2014 Oct; 86(4):780-9. PubMed ID: 24717299
[TBL] [Abstract][Full Text] [Related]
14. Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice.
Inoue A; Hasegawa H; Kohno M; Ito MR; Terada M; Imai T; Yoshie O; Nose M; Fujita S
Arthritis Rheum; 2005 May; 52(5):1522-33. PubMed ID: 15880599
[TBL] [Abstract][Full Text] [Related]
15. Anti-monocyte chemoattractant protein-1 gene therapy attenuates nephritis in MRL/lpr mice.
Shimizu S; Nakashima H; Masutani K; Inoue Y; Miyake K; Akahoshi M; Tanaka Y; Egashira K; Hirakata H; Otsuka T; Harada M
Rheumatology (Oxford); 2004 Sep; 43(9):1121-8. PubMed ID: 15213333
[TBL] [Abstract][Full Text] [Related]
16. Anti-macrophage-derived chemokine antibody relieves murine lupus nephritis.
Liu H; Diao C; Wu C; Xia L; Duan H; Fang F; Ding S; Xiao W
Rheumatol Int; 2011 Nov; 31(11):1459-64. PubMed ID: 20473504
[TBL] [Abstract][Full Text] [Related]
17. Microthrombotic Renal Vascular Lesions Are Associated to Increased Renal Inflammatory Infiltration in Murine Lupus Nephritis.
Gonzalo-Gil E; García-Herrero C; Toldos O; Usategui A; Criado G; Pérez-Yagüe S; Barber DF; Pablos JL; Galindo M
Front Immunol; 2018; 9():1948. PubMed ID: 30210500
[No Abstract] [Full Text] [Related]
18. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
[TBL] [Abstract][Full Text] [Related]
19. IL-34-Dependent Intrarenal and Systemic Mechanisms Promote Lupus Nephritis in MRL-
Wada Y; Gonzalez-Sanchez HM; Weinmann-Menke J; Iwata Y; Ajay AK; Meineck M; Kelley VR
J Am Soc Nephrol; 2019 Feb; 30(2):244-259. PubMed ID: 30622154
[TBL] [Abstract][Full Text] [Related]
20. Enhanced MHC class II expression in renal proximal tubules precedes loss of renal function in MRL/lpr mice with lupus nephritis.
Wuthrich RP; Yui MA; Mazoujian G; Nabavi N; Glimcher LH; Kelley VE
Am J Pathol; 1989 Jan; 134(1):45-51. PubMed ID: 2492404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
